Theranostics · 2018 · 69 citations · 34 references
PharmacyMolecular BiologyOncologyDrug DeliveryGene DeliveryNanoparticle Drug DeliveryCancer Drug DeliveryDrug Delivery EngineeringNanomaterials For Drug DeliveryNucleic Acid DeliveryNucleic Acid EngineeringSmall Interfering Rna DeliveryCharge ReversalControlled ReleaseControlled Release MaterialsCrosslinked PolymersDegradationNucleic Acid Delivery SystemsNucleic Acid EncapsulationNucleic Acid Nanotechnology
Stimuli-responsive polycations have been developed for improved nucleic acid transfection and enhanced therapeutic efficacy. The most reported mechanisms for controlled release of siRNA are based on polyelectrolyte exchange reactions in the cytoplasm and the degradation of polycations initiated by specific triggers. However, the degradation strategy has not always been sufficient due to unsatisfactory kinetics and binding of cationic fragments to siRNA, which limits the gene silencing effect. In this study, a new strategy that combines degradation and charge reversal is proposed. Methods: We prepared a polycation (CrossPPA) by crosslinking of phenylboronic acid (PBA)-grafted 1.8k PEI with alginate. It was compared with 25k PEI, 1.8k PEI and 1.8k PEI-PBA on siRNA encapsulation, ATP-responsive behavior and mechanism, cytotoxicity, cell uptake, siRNA transfection, in vivo biodistribution and in vivo anti-tumor efficacy. The in vitro and in vivo experiments were performed on 4T1 murine breast cancer cells and 4T1 tumor model separately.
34
ATP-triggered anticancer drug delivery
Ran Mo, Tianyue Jiang, Rocco DiSanto et al. · Nature Communications · 2014 · 676 citations · Full text
Medicine, Oncology, Pharmacology +12